FDA Adverse Event Injury Summary report: N

ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP

MDR report key: 3242814 · Received July 23, 2013

Report

Report Number
3005099803-2013-07508
Event Type
Injury
Date Received
July 23, 2013
Date of Event
March 18, 2013
Report Date
July 1, 2013
Manufacturer
BOSTON SCIENTIFIC - SPENCER
Product Code
KNT
PMA / PMN Number
K081739
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4) RELATES TO PNEUMOPERITONEUM. THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TWO-PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE) WAS BEING USED FOR THE PURPOSE OF ADMINISTERING MEDICATION FOR ADVANCED STAGE PARKINSON¿S DISEASE. THE PROCEDURE DATE WAS (B)(6) 2013. ACCORDING TO THE COMPLAINANT, THE TWO-PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE) WAS INADVERTENTLY PULLED OUT FROM THE PEG TUBE ON (B)(6) 2013. A NEW J-TUBE WAS PLACED ON (B)(6) 2013. ON (B)(6) 2013, THE PATIENT EXPERIENCED ABDOMINAL PAIN AND VOMITING. ON (B)(6) 2013 PATIENT EXPERIENCED MAJOR PNEUMOPERITONEUM AND INTESTINAL OCCLUSION REQUIRING SURGERY IN EMERGENCY. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
342551 ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP TUBES, GASTROINTESTINAL (AND ACCESSORIES) KNT BOSTON SCIENTIFIC - SPENCER UNK443

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other DUODOPA